The groundbreaking rise of Sildenafil presented a massive opportunity for the market, but its patent has lapsed , creating a challenging landscape. Off-brand versions have flooded the space , eroding sales and putting pressure on profit yields. While established healthcare companies continue a foothold in this field , the future looks unclear by fi